Interaction of retinoic acid and interferon in renal cancer cell lines

D. M. Nanus, Y. Geng, R. Shen, H. K. Lai, S. R. Pfeffer, Lawrence Pfeffer

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Retinoic acid (RA) can potentiate the antitumor effect of interferons (IFN) in a variety of tumor types, including renal cell carcinoma (RCC). The mechanisms by which RA and IFN increase the antitumor effects in RCC are unknown. We used growth assays and mobility shift assays to examine the effects of combining 13-cis-retinoic acid (CRA) and IFN-α (plus IFN-γ) on proliferation and on the expression of the IFN-specific transcription factor IFN-stimulated gene factor 3 (ISGF3) in RCC cell lines. Combining CRA and IFN-α resulted in a significant increase in growth inhibition in four cell lines compared with IFN-α or CRA alone. Binding of nuclear extracts from RCC cells to an IFN-stimulated response element (ISRE) oligonucleotide probe following incubation with IFN-α was not increased by CRA but was significantly increased by pretreatment by IFN-α in a time-dependent fashion. Proliferation assays showed that sequential addition of IFN-α and IFN-α significantly increased growth inhibition. IFN-α but not IFN-γ or CRA increased the cellular levels Stat2 and p48 but not Stat1. IFN-γ pretreatment enhanced the upregulation of p48 levels by IFN-α. Combining RA and IFN results in additive growth inhibition on RCC cell lines. This increase in growth inhibition is not mediated by increased ISGF3 expression.

Original languageEnglish (US)
Pages (from-to)787-794
Number of pages8
JournalJournal of Interferon and Cytokine Research
Volume20
Issue number9
DOIs
StatePublished - Oct 13 2000

Fingerprint

Kidney Neoplasms
Tretinoin
Interferons
Cell Line
NSC 153174
Renal Cell Carcinoma
Growth
Interferon-Stimulated Gene Factor 3
Isotretinoin
Oligonucleotide Probes
Response Elements
Electrophoretic Mobility Shift Assay

All Science Journal Classification (ASJC) codes

  • Immunology
  • Cell Biology
  • Virology

Cite this

Interaction of retinoic acid and interferon in renal cancer cell lines. / Nanus, D. M.; Geng, Y.; Shen, R.; Lai, H. K.; Pfeffer, S. R.; Pfeffer, Lawrence.

In: Journal of Interferon and Cytokine Research, Vol. 20, No. 9, 13.10.2000, p. 787-794.

Research output: Contribution to journalArticle

Nanus, D. M. ; Geng, Y. ; Shen, R. ; Lai, H. K. ; Pfeffer, S. R. ; Pfeffer, Lawrence. / Interaction of retinoic acid and interferon in renal cancer cell lines. In: Journal of Interferon and Cytokine Research. 2000 ; Vol. 20, No. 9. pp. 787-794.
@article{4d05999cc44d4dfd97d40c18ea635800,
title = "Interaction of retinoic acid and interferon in renal cancer cell lines",
abstract = "Retinoic acid (RA) can potentiate the antitumor effect of interferons (IFN) in a variety of tumor types, including renal cell carcinoma (RCC). The mechanisms by which RA and IFN increase the antitumor effects in RCC are unknown. We used growth assays and mobility shift assays to examine the effects of combining 13-cis-retinoic acid (CRA) and IFN-α (plus IFN-γ) on proliferation and on the expression of the IFN-specific transcription factor IFN-stimulated gene factor 3 (ISGF3) in RCC cell lines. Combining CRA and IFN-α resulted in a significant increase in growth inhibition in four cell lines compared with IFN-α or CRA alone. Binding of nuclear extracts from RCC cells to an IFN-stimulated response element (ISRE) oligonucleotide probe following incubation with IFN-α was not increased by CRA but was significantly increased by pretreatment by IFN-α in a time-dependent fashion. Proliferation assays showed that sequential addition of IFN-α and IFN-α significantly increased growth inhibition. IFN-α but not IFN-γ or CRA increased the cellular levels Stat2 and p48 but not Stat1. IFN-γ pretreatment enhanced the upregulation of p48 levels by IFN-α. Combining RA and IFN results in additive growth inhibition on RCC cell lines. This increase in growth inhibition is not mediated by increased ISGF3 expression.",
author = "Nanus, {D. M.} and Y. Geng and R. Shen and Lai, {H. K.} and Pfeffer, {S. R.} and Lawrence Pfeffer",
year = "2000",
month = "10",
day = "13",
doi = "10.1089/10799900050151058",
language = "English (US)",
volume = "20",
pages = "787--794",
journal = "Journal of Interferon and Cytokine Research",
issn = "1079-9907",
publisher = "Mary Ann Liebert Inc.",
number = "9",

}

TY - JOUR

T1 - Interaction of retinoic acid and interferon in renal cancer cell lines

AU - Nanus, D. M.

AU - Geng, Y.

AU - Shen, R.

AU - Lai, H. K.

AU - Pfeffer, S. R.

AU - Pfeffer, Lawrence

PY - 2000/10/13

Y1 - 2000/10/13

N2 - Retinoic acid (RA) can potentiate the antitumor effect of interferons (IFN) in a variety of tumor types, including renal cell carcinoma (RCC). The mechanisms by which RA and IFN increase the antitumor effects in RCC are unknown. We used growth assays and mobility shift assays to examine the effects of combining 13-cis-retinoic acid (CRA) and IFN-α (plus IFN-γ) on proliferation and on the expression of the IFN-specific transcription factor IFN-stimulated gene factor 3 (ISGF3) in RCC cell lines. Combining CRA and IFN-α resulted in a significant increase in growth inhibition in four cell lines compared with IFN-α or CRA alone. Binding of nuclear extracts from RCC cells to an IFN-stimulated response element (ISRE) oligonucleotide probe following incubation with IFN-α was not increased by CRA but was significantly increased by pretreatment by IFN-α in a time-dependent fashion. Proliferation assays showed that sequential addition of IFN-α and IFN-α significantly increased growth inhibition. IFN-α but not IFN-γ or CRA increased the cellular levels Stat2 and p48 but not Stat1. IFN-γ pretreatment enhanced the upregulation of p48 levels by IFN-α. Combining RA and IFN results in additive growth inhibition on RCC cell lines. This increase in growth inhibition is not mediated by increased ISGF3 expression.

AB - Retinoic acid (RA) can potentiate the antitumor effect of interferons (IFN) in a variety of tumor types, including renal cell carcinoma (RCC). The mechanisms by which RA and IFN increase the antitumor effects in RCC are unknown. We used growth assays and mobility shift assays to examine the effects of combining 13-cis-retinoic acid (CRA) and IFN-α (plus IFN-γ) on proliferation and on the expression of the IFN-specific transcription factor IFN-stimulated gene factor 3 (ISGF3) in RCC cell lines. Combining CRA and IFN-α resulted in a significant increase in growth inhibition in four cell lines compared with IFN-α or CRA alone. Binding of nuclear extracts from RCC cells to an IFN-stimulated response element (ISRE) oligonucleotide probe following incubation with IFN-α was not increased by CRA but was significantly increased by pretreatment by IFN-α in a time-dependent fashion. Proliferation assays showed that sequential addition of IFN-α and IFN-α significantly increased growth inhibition. IFN-α but not IFN-γ or CRA increased the cellular levels Stat2 and p48 but not Stat1. IFN-γ pretreatment enhanced the upregulation of p48 levels by IFN-α. Combining RA and IFN results in additive growth inhibition on RCC cell lines. This increase in growth inhibition is not mediated by increased ISGF3 expression.

UR - http://www.scopus.com/inward/record.url?scp=0033795736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033795736&partnerID=8YFLogxK

U2 - 10.1089/10799900050151058

DO - 10.1089/10799900050151058

M3 - Article

VL - 20

SP - 787

EP - 794

JO - Journal of Interferon and Cytokine Research

JF - Journal of Interferon and Cytokine Research

SN - 1079-9907

IS - 9

ER -